Selenium May Reduce Risk of Some Cancers CDC Daily UpdateImportant note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




Selenium May Reduce Risk of Some Cancers

Washington Post (12/25/96) P. A4


Abstract: A new study, led by University of Arizona epidemiologist Larry Clark, shows that selenium, which is currently being trumpeted as being a treatment for everything from dandruff to AIDS, could reduce the risk for certain types of cancer, including prostate, colon, rectal, and lung. Selenium is a mineral found in seafood, liver, and vegetables grown in selenium-rich soil. The research indicated that, when compared with participants who received a placebo, patients who took daily doses of selenium had 63 percent fewer cases of prostate cancer, 58 percent less colon or rectal cancers, and a 45 percent reduction in lung cancer. However, researchers warned in the Journal of the American Medical Association that the results need to be repeated since the study was originally created to monitor whether selenium could prevent skin cancer- -which it did not--and because 75 percent of the participants were men.


961226
AD962441


Copyright © 1996 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.